Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Assura completes £25 million asset disposal

EditorFrank DeMatteo
Published 24/10/2024, 11:42 pm
© Reuters.
AGRP
-

LONDON - Assura plc, a prominent UK healthcare real estate investment trust (REIT), has concluded the sale of 12 properties, totaling £25 million in cash proceeds. The transaction aligns with the assets' book value and will contribute to a partial repayment of the group's revolving credit facility.

The completed sale is part of a broader disposal strategy that Assura embarked upon following its substantial £500 million private hospital portfolio acquisition in August 2024. The company is actively negotiating additional disposals expected to reach approximately £110 million. These discussions include a mix of portfolio sales and transfers of assets into a joint venture partnership previously announced.

Furthermore, Assura has identified a pipeline of 27 assets, valued at around £90 million, which fit the disposal criteria. Preliminary steps towards their potential sale have begun. This strategic move aims to decrease the company's net debt to EBITDA ratio to below nine times and its loan-to-value (LTV) ratio to under 45% within the next 18 to 24 months.

Jonathan Murphy, CEO of Assura, expressed satisfaction with the recent transactions, highlighting their alignment with the book value and the attractiveness of the healthcare asset class they represent. He reiterated the importance of the August acquisition in diversifying Assura's portfolio and emphasized the disposals program as a key element in the company's commitment to reducing leverage post-acquisition.

Investors can expect a detailed update on Assura's disposal program during the half-year results presentation scheduled for 14 November 2024.

This strategic divestment initiative is part of Assura's ongoing efforts to optimize its portfolio and strengthen its financial position. The information provided is based on a press release statement from Assura.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.